Filing Details
Climb Bio, Inc. (NASDAQ:CLYM) filed a Form 8-K with the Securities and Exchange Commission on August 14, 2026, disclosing a material event.
8k filedNASDAQ:CLYM
Climb Bio, Inc. (CLYM) Reports Material Event to SEC
Climb Bio, Inc. (NASDAQ:CLYM) filed a Form 8-K with the Securities and Exchange Commission on August 14, 2026, disclosing a material event.
At publication ·
What changed
Climb Bio, Inc. (NASDAQ:CLYM) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Climb Bio, Inc. (NASDAQ: CLYM) filed a Form 8-K with the SEC on August 14, 2026, disclosing a material event that shareholders should be aware of.
- The company's stock trades at $16.33 with a market capitalization of $157.2 million.
- The article does not specify the nature of the material event, which could involve leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance.
Market Context
Climb Bio, Inc.'s stock currently trades at $16.33 with a market capitalization of $157.2M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Climb Bio, Inc.'s stock.
All SEC filings for Climb Bio, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CLYM Stock Page
Frequently Asked Questions
Where can I read CLYM's SEC filings?
Browse all filings on our CLYM SEC filings page.
What types of SEC filings does Climb Bio, Inc. file?
Public companies like Climb Bio, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.